X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (34047) 34047
Newsletter (5743) 5743
Publication (3246) 3246
Book Chapter (207) 207
Magazine Article (194) 194
Dissertation (183) 183
Newspaper Article (140) 140
Book Review (116) 116
Journal / eJournal (100) 100
Web Resource (69) 69
Conference Proceeding (61) 61
Book / eBook (46) 46
Government Document (32) 32
Trade Publication Article (29) 29
Reference (16) 16
Report (11) 11
Data Set (4) 4
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16298) 16298
animals (15844) 15844
leishmaniasis (15720) 15720
index medicus (9236) 9236
female (8708) 8708
male (8475) 8475
visceral leishmaniasis (7810) 7810
cutaneous leishmaniasis (6299) 6299
parasitic diseases (5671) 5671
parasitology (5618) 5618
mice (5371) 5371
research (4967) 4967
adult (4754) 4754
tropical medicine (4736) 4736
immunology (4547) 4547
infectious diseases (3786) 3786
microbiology (3178) 3178
dogs (3174) 3174
mice, inbred balb c (2947) 2947
child (2912) 2912
middle aged (2898) 2898
leishmania (2856) 2856
infection (2784) 2784
adolescent (2750) 2750
diagnosis (2708) 2708
parasites (2671) 2671
leishmaniasis, cutaneous (2494) 2494
kala-azar (2484) 2484
epidemiology (2427) 2427
analysis (2386) 2386
health aspects (2344) 2344
leishmaniasis, visceral - drug therapy (2238) 2238
medical research (2231) 2231
leishmaniasis, visceral - diagnosis (2204) 2204
antiprotozoal agents - therapeutic use (2131) 2131
public, environmental & occupational health (2128) 2128
leishmaniasis, visceral - epidemiology (2084) 2084
leishmaniasis, visceral - parasitology (2080) 2080
child, preschool (2013) 2013
medicine, experimental (1995) 1995
brazil (1936) 1936
leishmaniasis, visceral - immunology (1879) 1879
infections (1840) 1840
leishmaniasis, cutaneous - parasitology (1831) 1831
research article (1807) 1807
leishmaniasis, cutaneous - immunology (1723) 1723
veterinary sciences (1722) 1722
macrophages (1700) 1700
arctic medicine. tropical medicine (1687) 1687
care and treatment (1582) 1582
infant (1429) 1429
leishmania infantum (1422) 1422
polymerase chain reaction (1407) 1407
medicine (1398) 1398
leishmaniasis, cutaneous - drug therapy (1376) 1376
leishmaniasis - immunology (1359) 1359
leishmaniasis, visceral - veterinary (1346) 1346
pharmacology & pharmacy (1343) 1343
aged (1328) 1328
antiprotozoal agents - pharmacology (1315) 1315
leishmaniasis, cutaneous - epidemiology (1312) 1312
vector-borne diseases (1300) 1300
tropical diseases (1290) 1290
leishmaniasis - parasitology (1275) 1275
vaccines (1268) 1268
leishmaniasis - drug therapy (1239) 1239
interferon-gamma (1220) 1220
leishmania - isolation & purification (1196) 1196
donovani (1192) 1192
identification (1192) 1192
risk factors (1176) 1176
leishmaniasis - epidemiology (1166) 1166
antigens (1159) 1159
skin (1158) 1158
antigens, protozoan - immunology (1139) 1139
leishmaniasis, cutaneous - diagnosis (1136) 1136
mice, inbred c57bl (1123) 1123
leishmaniasis, visceral - complications (1120) 1120
antibodies, protozoan - blood (1118) 1118
leishmania - immunology (1100) 1100
biochemistry & molecular biology (1099) 1099
leishmaniasis, cutaneous - pathology (1090) 1090
dog diseases - parasitology (1080) 1080
cricetinae (1073) 1073
psychodidae (1072) 1072
universities and colleges (1069) 1069
infantum (1060) 1060
macrophages - parasitology (1050) 1050
young adult (1040) 1040
leishmania donovani (1031) 1031
dermatology (1029) 1029
expression (1009) 1009
leishmania major (1000) 1000
enzyme-linked immunosorbent assay (978) 978
promastigotes (977) 977
disease models, animal (962) 962
proteins (962) 962
cytokines (961) 961
reports (953) 953
zoonoses (947) 947
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (22) 22
Online Resources - Online (12) 12
Gerstein Science - Periodical Stacks (3) 3
Gerstein Science - Bindery (2) 2
Gerstein Science - Theses (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Circulation Desk (1) 1
Robarts - Government Pubs (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (35296) 35296
French (1378) 1378
Portuguese (1298) 1298
Spanish (1027) 1027
Russian (474) 474
German (426) 426
Italian (223) 223
Turkish (123) 123
Chinese (90) 90
Persian (85) 85
Dutch (39) 39
Polish (21) 21
Hebrew (18) 18
Czech (15) 15
Japanese (13) 13
Danish (12) 12
Korean (11) 11
Swedish (11) 11
Norwegian (10) 10
Hungarian (9) 9
Serbian (9) 9
Romanian (7) 7
Arabic (5) 5
Bulgarian (5) 5
Croatian (5) 5
Finnish (3) 3
Greek (3) 3
Slovak (3) 3
Azerbaijani (1) 1
Bosnian (1) 1
Icelandic (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Dermatologic Clinics, ISSN 0733-8635, 2015, Volume 33, Issue 3, pp. 579 - 593
Journal Article
The Lancet, ISSN 0140-6736, 10/1999, Volume 354, Issue 9185, pp. 1191 - 1199
In 1903, Leishman and Donovan separately described the protozoan now called Leishmania donovani in splenic tissue from patients in India with the... 
CUTANEOUS LEISHMANIASIS | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | MUCOCUTANEOUS LEISHMANIASIS | INDIAN VISCERAL LEISHMANIASIS | CYTOKINE RESPONSES | DNA | GUATEMALA | KALA-AZAR | NATURAL-HISTORY | CELL | Leishmaniasis - immunology | Leishmaniasis - diagnosis | Drug Administration Schedule | Leishmaniasis, Cutaneous - diagnosis | Humans | Leishmaniasis - drug therapy | Male | Leishmaniasis, Cutaneous - drug therapy | Leishmaniasis, Visceral - drug therapy | Leishmaniasis, Mucocutaneous - drug therapy | Animals | Leishmaniasis - transmission | Leishmaniasis, Mucocutaneous - diagnosis | HIV Infections - complications | Leishmaniasis, Visceral - complications | Female | Amphotericin B - therapeutic use | Antimony - therapeutic use | Antiprotozoal Agents - therapeutic use | Leishmania - isolation & purification | Leishmaniasis, Visceral - diagnosis | Care and treatment | Leishmaniasis | Protozoa | Disease | Developing countries | Lipids | Skin | LDCs | Drug therapy | Epidemics | Pathogenesis | Mucosa | Opportunist infection | Infections | Vaccines | Parasites | Tropical diseases | Acquired immune deficiency syndrome--AIDS | Parasitic diseases | Visceral leishmaniasis | Diagnosis | Drug dosages | Immune system | Formulations | Vector-borne diseases | Spleen | Pathogens | Antigens | Immune response | Cytokines | Medical treatment | Antimony | Molecular chains | Amphotericin B | Antimony compounds
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 10/2011, Volume 17, Issue 10, pp. 1478 - 1483
Although there have been significant advances in the treatment of visceral leishmaniasis (VL), there remain challenges to ensure that treatments effective in... 
Cutaneous leishmaniasis | standardization | drug sensitivity | HIV co-infection | visceral leishmaniasis | HIV co‐infection | Visceral leishmaniasis | Drug sensitivity | Standardization | INFECTIOUS DISEASES | ORAL MILTEFOSINE | EFFICACY | RANDOMIZED-TRIAL | MICROBIOLOGY | DRUG-RESISTANCE | LIPOSOMAL AMPHOTERICIN-B | INDIAN VISCERAL LEISHMANIASIS | AZAR DERMAL LEISHMANIASIS | IN-VIVO | WORLD CUTANEOUS LEISHMANIASIS | DOUBLE-BLIND | Coinfection - drug therapy | Humans | Research - organization & administration | Coinfection - parasitology | Anti-HIV Agents - administration & dosage | Leishmaniasis, Cutaneous - epidemiology | Anti-HIV Agents - therapeutic use | Leishmaniasis, Visceral - parasitology | Clinical Trials as Topic - standards | Paromomycin - therapeutic use | HIV Infections - virology | Paromomycin - administration & dosage | India - epidemiology | Leishmaniasis, Cutaneous - drug therapy | HIV - pathogenicity | Coinfection - virology | Drug Discovery | Leishmaniasis, Visceral - drug therapy | Leishmaniasis, Cutaneous - parasitology | Antiprotozoal Agents - administration & dosage | HIV Infections - drug therapy | HIV Infections - parasitology | Leishmania - pathogenicity | Antiprotozoal Agents - therapeutic use | Leishmaniasis, Visceral - epidemiology | Chemotherapy | Leishmaniasis | Universities and colleges | HIV (Viruses) | Analysis | Cancer | Research & development--R&D | Parasitic diseases
Journal Article
Veterinary Parasitology, ISSN 0304-4017, 09/2018, Volume 261, pp. 9 - 17
( ) -infected dogs may present with a large range of clinical signs, from apparently healthy with no or few (asymptomatic dogs, AD) to several clinical signs... 
Leishmania infantum | IgG1 and IgG2 isotypes | Autoantibodies | Human transferrin | Canine visceral leishmaniasis | CANINE LEISHMANIASIS | IgGI and 15G2 isotypes | ANTINUCLEAR ANTIBODIES | RESPONSES | SUBCLASS DISTRIBUTION | B-CELL ACTIVATION | IGG2 ANTIBODY | VETERINARY SCIENCES | PROTEINS | VISCERAL LEISHMANIASIS | IMMUNOGLOBULIN-G | PARASITOLOGY | CIRCULATING IMMUNE-COMPLEXES | Prevalence | Antibodies, Protozoan | Seroepidemiologic Studies | Leishmaniasis, Visceral - immunology | Blotting, Western - veterinary | Autoantibodies - immunology | Leishmaniasis, Visceral - veterinary | Animals | Leishmania infantum - isolation & purification | Dog Diseases - immunology | Immunoglobulin G - immunology | Dogs | Enzyme-Linked Immunosorbent Assay - veterinary | Leishmaniasis, Visceral - parasitology | Dog Diseases - diagnosis | Dog Diseases - parasitology | Leishmaniasis, Visceral - diagnosis | Tunisia - epidemiology | Proteins | Autoimmunity | Antigens | Immunoglobulin G | Leishmaniasis | Comparative analysis | Protein binding | Enzyme-Linked Immunosorbent Assay/veterinary | Tunisia/epidemiology | Leishmaniasis, Visceral/parasitology | Leishmania infantum/isolation & purification | Autoantibodies/immunology | Animal biology | Dog Diseases/diagnosis | Blotting, Western/veterinary | Leishmaniasis, Visceral/diagnosis | Life Sciences | Microbiology and Parasitology | Leishmaniasis, Visceral/immunology | Immunology | Veterinary medicine and animal Health | Immunoglobulin G/immunology | Dog Diseases/immunology | Leishmaniasis, Visceral/veterinary | Dog Diseases/parasitology
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 2014, Volume 8, Issue 11, p. e3258
Background: Co-infection of leishmaniasis and HIV is increasingly reported. The clinical presentation of leishmaniasis is determined by the host immune... 
MUCOCUTANEOUS LEISHMANIASIS | DISSEMINATED CUTANEOUS LEISHMANIASIS | RECONSTITUTION INFLAMMATORY SYNDROME | AIDS PATIENT | ACTIVE ANTIRETROVIRAL THERAPY | KALA-AZAR | HERPES-ZOSTER LESIONS | HUMAN-IMMUNODEFICIENCY-VIRUS | VISCERAL LEISHMANIASIS | PARASITOLOGY | TROPICAL MEDICINE | LIPOSOMAL AMPHOTERICIN-B | Coinfection | Humans | Leishmaniasis, Mucocutaneous - pathology | Male | Leishmaniasis, Visceral - immunology | Skin Diseases - pathology | Leishmaniasis, Cutaneous - complications | Leishmaniasis, Cutaneous - immunology | HIV Infections - immunology | HIV Infections - pathology | Leishmaniasis, Visceral - complications | Adult | Female | Immunocompetence | Skin - pathology | Leishmaniasis, Mucocutaneous - immunology | Leishmania donovani - immunology | Leishmaniasis, Diffuse Cutaneous - pathology | Leishmaniasis, Cutaneous - pathology | Skin - parasitology | Skin Diseases - immunology | Leishmaniasis, Diffuse Cutaneous - complications | Leishmania - immunology | Leishmaniasis, Visceral - pathology | Skin Diseases - complications | HIV Infections - complications | Leishmaniasis, Mucocutaneous - complications | Leishmaniasis, Diffuse Cutaneous - immunology | Physiological aspects | Immune response | Leishmaniasis | Tropical diseases | AIDS | Parasites | Human immunodeficiency virus | Acquired immune deficiency syndrome | HIV | Parasitic diseases
Journal Article